Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | +0.58% | -7.64% | -48.67% |
May. 30 | Evercore ISI Cuts Price Target on Editas Medicine to $7 From $15, Maintains In Line Rating | MT |
May. 14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.67% | 428M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Credit Suisse Trims Editas Medicine's Price Target to $14 From $15, Keeps Neutral Rating